| 90 |
ABS - IUPUI |
Lung squamous cell carcinoma |
IGC |
| 91 |
ABS - IUPUI |
Lung adenocarcinoma |
IGC |
| GD |
ABS - IUPUI |
Bladder Urothelial Carcinoma |
NCH |
| GE |
ABS - IUPUI |
Thyroid carcinoma |
NCH |
| GF |
ABS - IUPUI |
Skin Cutaneous Melanoma |
NCH |
| GG |
ABS - IUPUI |
Uterine Corpus Endometrial Carcinoma |
NCH |
| GH |
ABS - IUPUI |
Cervical squamous cell carcinoma and endocervical adenocarcinoma |
NCH |
| GI |
ABS - IUPUI |
Breast invasive carcinoma |
NCH |
| GJ |
ABS - IUPUI |
Liver hepatocellular carcinoma |
NCH |
| GK |
ABS - IUPUI |
Kidney renal clear cell carcinoma |
IGC |
| GL |
ABS - IUPUI |
Kidney renal papillary cell carcinoma |
IGC |
| H3 |
ABS - IUPUI |
Lymphoid Neoplasm Diffuse Large B-cell Lymphoma |
IGC |
| H7 |
ABS - IUPUI |
Head and Neck squamous cell carcinoma |
IGC |
| H8 |
ABS - IUPUI |
Pancreatic adenocarcinoma |
IGC |
| H9 |
ABS - IUPUI |
Prostate adenocarcinoma |
IGC |
| IE |
ABS - IUPUI |
Sarcoma |
NCH |
| IP |
ABS - IUPUI |
Stomach adenocarcinoma |
IGC |
| S8 |
ABS - IUPUI |
Esophageal carcinoma |
NCH |
| SA |
ABS - IUPUI |
Pheochromocytoma and Paraganglioma |
NCH |
| IZ |
ABS - Lahey Clinic |
Kidney renal papillary cell carcinoma |
IGC |
| J1 |
ABS - Lahey Clinic |
Lung squamous cell carcinoma |
IGC |
| J2 |
ABS - Lahey Clinic |
Lung adenocarcinoma |
IGC |
| J4 |
ABS - Lahey Clinic |
Prostate adenocarcinoma |
IGC |
| K4 |
ABS - Lahey Clinic |
Bladder Urothelial Carcinoma |
NCH |
| K6 |
ABS - Lahey Clinic |
Uterine Corpus Endometrial Carcinoma |
NCH |
| K7 |
ABS - Lahey Clinic |
Liver hepatocellular carcinoma |
NCH |
| K8 |
ABS - Lahey Clinic |
Skin Cutaneous Melanoma |
NCH |
| KA |
ABS - Lahey Clinic |
Esophageal carcinoma |
NCH |
| PZ |
ABS - Lahey Clinic |
Pancreatic adenocarcinoma |
NCH |
| JA |
ABS - Research Metrics Pakistan |
Head and Neck squamous cell carcinoma |
IGC |
| JL |
ABS - Research Metrics Pakistan |
Breast invasive carcinoma |
NCH |
| 2X |
ABS IUPUI |
Testicular Germ Cell Tumors |
NCH |
| X7 |
ABS IUPUI |
Thymoma |
NCH |
| 3L |
Albert Einstein Medical Center |
Colon adenocarcinoma |
NCH |
| S2 |
Albert Einstein Medical Center |
Lung adenocarcinoma |
NCH |
| S3 |
Albert Einstein Medical Center |
Breast invasive carcinoma |
NCH |
| SJ |
Albert Einstein Medical Center |
Uterine Corpus Endometrial Carcinoma |
NCH |
| VZ |
Albert Einstein Medical Center |
Pheochromocytoma and Paraganglioma |
NCH |
| XB |
Albert Einstein Medical Center |
Esophageal carcinoma |
NCH |
| XC |
Albert Einstein Medical Center |
Lung squamous cell carcinoma |
NCH |
| YW |
Albert Einstein Medical Center |
Sarcoma |
NCH |
| 3X |
Alberta Health Services |
Cholangiocarcinoma |
NCH |
| G3 |
Alberta Health Services |
Liver hepatocellular carcinoma |
NCH |
| HA |
Alberta Health Services |
Stomach adenocarcinoma |
IGC |
| IB |
Alberta Health Services |
Pancreatic adenocarcinoma |
IGC |
| VA |
Alliance |
Stomach adenocarcinoma |
NCH |
| UT |
Asbestos Diseases Research Institute |
Mesothelioma |
NCH |
| 85 |
Asterand |
Lung squamous cell carcinoma |
IGC |
| 86 |
Asterand |
Lung adenocarcinoma |
IGC |
| BR |
Asterand |
Stomach adenocarcinoma |
IGC |
| E7 |
Asterand |
Bladder Urothelial Carcinoma |
NCH |
| E8 |
Asterand |
Thyroid carcinoma |
NCH |
| E9 |
Asterand |
Breast invasive carcinoma |
NCH |
| EA |
Asterand |
Cervical squamous cell carcinoma and endocervical adenocarcinoma |
NCH |
| EB |
Asterand |
Skin Cutaneous Melanoma |
NCH |
| EC |
Asterand |
Uterine Corpus Endometrial Carcinoma |
NCH |
| ED |
Asterand |
Liver hepatocellular carcinoma |
NCH |
| F4 |
Asterand |
Colon adenocarcinoma |
IGC |
| F5 |
Asterand |
Rectum adenocarcinoma |
IGC |
| F6 |
Asterand |
Brain Lower Grade Glioma |
IGC |
| F7 |
Asterand |
Head and Neck squamous cell carcinoma |
IGC |
| F9 |
Asterand |
Kidney renal papillary cell carcinoma |
IGC |
| FA |
Asterand |
Lymphoid Neoplasm Diffuse Large B-cell Lymphoma |
IGC |
| FB |
Asterand |
Pancreatic adenocarcinoma |
IGC |
| FC |
Asterand |
Prostate adenocarcinoma |
IGC |
| IG |
Asterand |
Esophageal carcinoma |
NCH |
| UE |
Asterand |
Sarcoma |
NCH |
| 4Z |
Barretos Cancer Hospital |
Bladder Urothelial Carcinoma |
NCH |
| UF |
Barretos Cancer Hospital |
Head and Neck squamous cell carcinoma |
NCH |
| VQ |
Barretos Cancer Hospital |
Stomach adenocarcinoma |
NCH |
| VR |
Barretos Cancer Hospital |
Esophageal carcinoma |
NCH |
| VS |
Barretos Cancer Hospital |
Cervical squamous cell carcinoma and endocervical adenocarcinoma |
NCH |
| YR |
Barretos Cancer Hospital |
Cholangiocarcinoma |
NCH |
| YS |
Barretos Cancer Hospital |
Mesothelioma |
NCH |
| YT |
Barretos Cancer Hospital |
Thymoma |
NCH |
| YU |
Barretos Cancer Hospital |
Testicular Germ Cell Tumors |
NCH |
| SB |
Baylor College of Medicine |
Testicular Germ Cell Tumors |
NCH |
| KG |
Baylor Network |
Pancreatic adenocarcinoma |
IGC |
| 36 |
BC Cancer Agency |
Ovarian serous cystadenocarcinoma |
IGC |
| GZ |
BC Cancer Agency |
Lymphoid Neoplasm Diffuse Large B-cell Lymphoma |
IGC |
| FJ |
BLN - Baylor |
Bladder Urothelial Carcinoma |
NCH |
| JU |
BLN - Baylor |
Uterine Corpus Endometrial Carcinoma |
NCH |
| JV |
BLN - Baylor |
Sarcoma |
NCH |
| JW |
BLN - Baylor |
Cervical squamous cell carcinoma and endocervical adenocarcinoma |
NCH |
| MG |
BLN - Baylor |
Prostate adenocarcinoma |
NCH |
| MH |
BLN - Baylor |
Kidney renal papillary cell carcinoma |
NCH |
| MI |
BLN - Baylor |
Liver hepatocellular carcinoma |
NCH |
| MJ |
BLN - Baylor |
Sarcoma |
NCH |
| MK |
BLN - Baylor |
Thyroid carcinoma |
NCH |
| ML |
BLN - Baylor |
Lung squamous cell carcinoma |
NCH |
| MM |
BLN - Baylor |
Kidney renal clear cell carcinoma |
NCH |
| MN |
BLN - Baylor |
Lung adenocarcinoma |
NCH |
| QF |
BLN - Baylor |
Uterine Corpus Endometrial Carcinoma |
NCH |
| QG |
BLN - Baylor |
Colon adenocarcinoma |
NCH |
| RH |
BLN - Baylor |
Head and Neck squamous cell carcinoma |
NCH |
| SN |
BLN - Baylor |
Testicular Germ Cell Tumors |
NCH |
| GV |
BLN - Cleveland Clinic |
Bladder Urothelial Carcinoma |
NCH |
| FD |
BLN - University Of Chicago |
Bladder Urothelial Carcinoma |
NCH |
| FT |
BLN - University of Miami |
Bladder Urothelial Carcinoma |
NCH |
| GU |
BLN - UT Southwestern Medical Center at Dallas |
Bladder Urothelial Carcinoma |
NCH |
| XH |
BLN Baylor |
Thymoma |
NCH |
| XG |
BLN UT Southwestern Medical Center at Dallas |
Pheochromocytoma and Paraganglioma |
NCH |
| 3K |
Boston Medical Center |
Liver hepatocellular carcinoma |
NCH |
| SE |
Boston Medical Center |
Pheochromocytoma and Paraganglioma |
NCH |
| UJ |
Boston Medical Center |
Lung squamous cell carcinoma |
NCH |
| UL |
Boston Medical Center |
Breast invasive carcinoma |
NCH |
| UN |
Boston Medical Center |
Kidney renal papillary cell carcinoma |
NCH |
| UP |
Boston Medical Center |
Head and Neck squamous cell carcinoma |
NCH |
| UR |
Boston Medical Center |
Prostate adenocarcinoma |
NCH |
| WK |
Brigham and Women's Hospital |
Sarcoma |
NCH |
| ZN |
Brigham and Women's Hospital Division of Thoracic Surgery |
Mesothelioma |
NCH |
| KP |
British Columbia Cancer Agency |
Uterine Corpus Endometrial Carcinoma |
NCH |
| NM |
Cambridge BioSource |
Head and Neck squamous cell carcinoma |
NCH |
| L9 |
Candler |
Lung adenocarcinoma |
IGC |
| LA |
Candler |
Lung squamous cell carcinoma |
IGC |
| LB |
Candler |
Pancreatic adenocarcinoma |
IGC |
| LL |
Candler |
Breast invasive carcinoma |
NCH |
| NH |
Candler |
Colon adenocarcinoma |
NCH |
| QS |
Candler |
Uterine Corpus Endometrial Carcinoma |
NCH |
| R9 |
Candler |
Ovarian serous cystadenocarcinoma |
NCH |
| RA |
Candler |
Cervical squamous cell carcinoma and endocervical adenocarcinoma |
NCH |
| ZA |
Candler |
Stomach adenocarcinoma |
NCH |
| UV |
Capital Biosciences |
Liver hepatocellular carcinoma |
NCH |
| XV |
Capital Biosciences |
Skin Cutaneous Melanoma |
NCH |
| 3J |
Carle Cancer Center |
Breast invasive carcinoma |
NCH |
| 19 |
Case Western |
Glioblastoma multiforme |
IGC |
| FG |
Case Western |
Brain Lower Grade Glioma |
IGC |
| HT |
Case Western - St Joes |
Brain Lower Grade Glioma |
IGC |
| 23 |
Cedars Sinai |
Ovarian serous cystadenocarcinoma |
IGC |
| 28 |
Cedars Sinai |
Glioblastoma multiforme |
IGC |
| A5 |
Cedars Sinai |
Uterine Corpus Endometrial Carcinoma |
NCH |
| DS |
Cedars Sinai |
Cervical squamous cell carcinoma and endocervical adenocarcinoma |
NCH |
| IW |
Cedars Sinai |
Sarcoma |
NCH |
| ND |
Cedars Sinai |
Uterine Carcinosarcoma |
NCH |
| 81 |
CHI-Penrose Colorado |
Glioblastoma multiforme |
IGC |
| 82 |
CHI-Penrose Colorado |
Lung squamous cell carcinoma |
IGC |
| 83 |
CHI-Penrose Colorado |
Lung adenocarcinoma |
IGC |
| EU |
CHI-Penrose Colorado |
Kidney renal clear cell carcinoma |
IGC |
| EV |
CHI-Penrose Colorado |
Kidney renal papillary cell carcinoma |
IGC |
| FH |
CHI-Penrose Colorado |
Thyroid carcinoma |
NCH |
| R1 |
CHI-Penrose Colorado |
Colon adenocarcinoma |
NCH |
| R2 |
CHI-Penrose Colorado |
Cervical squamous cell carcinoma and endocervical adenocarcinoma |
NCH |
| R3 |
CHI-Penrose Colorado |
Bladder Urothelial Carcinoma |
NCH |
| L7 |
Christiana Care |
Esophageal carcinoma |
NCH |
| 41 |
Christiana Healthcare |
Glioblastoma multiforme |
IGC |
| 42 |
Christiana Healthcare |
Ovarian serous cystadenocarcinoma |
IGC |
| 43 |
Christiana Healthcare |
Lung squamous cell carcinoma |
IGC |
| 44 |
Christiana Healthcare |
Lung adenocarcinoma |
IGC |
| A6 |
Christiana Healthcare |
Colon adenocarcinoma |
IGC |
| A7 |
Christiana Healthcare |
Breast invasive carcinoma |
NCH |
| AF |
Christiana Healthcare |
Rectum adenocarcinoma |
IGC |
| B2 |
Christiana Healthcare |
Kidney renal clear cell carcinoma |
IGC |
| B3 |
Christiana Healthcare |
Kidney renal papillary cell carcinoma |
IGC |
| BK |
Christiana Healthcare |
Uterine Corpus Endometrial Carcinoma |
NCH |
| BL |
Christiana Healthcare |
Bladder Urothelial Carcinoma |
NCH |
| EP |
Christiana Healthcare |
Liver hepatocellular carcinoma |
NCH |
| EQ |
Christiana Healthcare |
Stomach adenocarcinoma |
IGC |
| H2 |
Christiana Healthcare |
Thyroid carcinoma |
NCH |
| H6 |
Christiana Healthcare |
Pancreatic adenocarcinoma |
IGC |
| HM |
Christiana Healthcare |
Cervical squamous cell carcinoma and endocervical adenocarcinoma |
NCH |
| IJ |
Christiana Healthcare |
Acute Myeloid Leukemia |
NCH |
| IK |
Christiana Healthcare |
Brain Lower Grade Glioma |
IGC |
| KF |
Christiana Healthcare |
Sarcoma |
NCH |
| IA |
Cleveland Clinic |
Kidney renal papillary cell carcinoma |
IGC |
| 5G |
Cleveland Clinic Foundation |
Thymoma |
NCH |
| RT |
Cleveland Clinic Foundation |
Pheochromocytoma and Paraganglioma |
NCH |
| SG |
Cleveland Clinic Foundation |
Sarcoma |
NCH |
| V2 |
Cleveland Clinic Foundation |
Prostate adenocarcinoma |
NCH |
| V3 |
Cleveland Clinic Foundation |
Uveal Melanoma |
NCH |
| X3 |
Cleveland Clinic Foundation |
Testicular Germ Cell Tumors |
NCH |
| 3C |
Columbia University |
Breast invasive carcinoma |
NCH |
| 3E |
Columbia University |
Pancreatic adenocarcinoma |
NCH |
| KC |
Cornell Medical College |
Prostate adenocarcinoma |
IGC |
| KQ |
Cornell Medical College |
Bladder Urothelial Carcinoma |
NCH |
| 35 |
Cureline |
Lung adenocarcinoma |
IGC |
| 37 |
Cureline |
Lung squamous cell carcinoma |
IGC |
| 5C |
Cureline |
Liver hepatocellular carcinoma |
NCH |
| 5J |
Cureline |
Acute Myeloid Leukemia |
NCH |
| AM |
Cureline |
Colon adenocarcinoma |
IGC |
| AN |
Cureline |
Breast invasive carcinoma |
NCH |
| AW |
Cureline |
Uterine Corpus Endometrial Carcinoma |
NCH |
| B4 |
Cureline |
Kidney renal clear cell carcinoma |
IGC |
| B7 |
Cureline |
Stomach adenocarcinoma |
IGC |
| BF |
Cureline |
Skin Cutaneous Melanoma |
NCH |
| EF |
Cureline |
Rectum adenocarcinoma |
IGC |
| P5 |
Cureline |
Brain Lower Grade Glioma |
NCH |
| Z4 |
Cureline |
Sarcoma |
NCH |
| Z5 |
Cureline |
Pancreatic adenocarcinoma |
NCH |
| Z6 |
Cureline |
Esophageal carcinoma |
NCH |
| S9 |
Dept of Neurosurgery at University of Heidelberg |
Brain Lower Grade Glioma |
NCH |
| 12 |
Duke |
Glioblastoma multiforme |
IGC |
| 29 |
Duke |
Ovarian serous cystadenocarcinoma |
IGC |
| B5 |
Duke |
Uterine Corpus Endometrial Carcinoma |
NCH |
| B6 |
Duke |
Breast invasive carcinoma |
NCH |
| E1 |
Duke |
Brain Lower Grade Glioma |
IGC |
| 4P |
Duke University |
Head and Neck squamous cell carcinoma |
NCH |
| 4Q |
Duke University |
Sarcoma |
NCH |
| 4R |
Duke University |
Liver hepatocellular carcinoma |
NCH |
| 4S |
Duke University |
Prostate adenocarcinoma |
NCH |
| 4T |
Duke University |
Colon adenocarcinoma |
NCH |
| 5F |
Duke University |
Thyroid carcinoma |
NCH |
| NA |
Duke University |
Uterine Carcinosarcoma |
NCH |
| V5 |
Duke University |
Esophageal carcinoma |
NCH |
| V6 |
Duke University |
Stomach adenocarcinoma |
NCH |
| 14 |
Emory University |
Glioblastoma multiforme |
IGC |
| 3T |
Emory University |
Thymoma |
NCH |
| Q4 |
Emory University |
Acute Myeloid Leukemia |
NCH |
| Q9 |
Emory University |
Esophageal carcinoma |
NCH |
| QA |
Emory University |
Liver hepatocellular carcinoma |
NCH |
| QB |
Emory University |
Skin Cutaneous Melanoma |
NCH |
| QC |
Emory University |
Sarcoma |
NCH |
| QD |
Emory University |
Thyroid carcinoma |
NCH |
| RB |
Emory University |
Pancreatic adenocarcinoma |
NCH |
| WD |
Emory University |
Cholangiocarcinoma |
NCH |
| YX |
Emory University |
Stomach adenocarcinoma |
NCH |
| QK |
Emory University - Winship Cancer Inst. |
Head and Neck squamous cell carcinoma |
NCH |
| 2F |
Erasmus MC |
Bladder Urothelial Carcinoma |
NCH |
| 2G |
Erasmus MC |
Testicular Germ Cell Tumors |
NCH |
| 2H |
Erasmus MC |
Esophageal carcinoma |
NCH |
| WB |
Erasmus MC |
Pheochromocytoma and Paraganglioma |
NCH |
| FS |
Essen |
Skin Cutaneous Melanoma |
NCH |
| QH |
Fondazione-Besta |
Brain Lower Grade Glioma |
NCH |
| 64 |
Fox Chase |
Lung adenocarcinoma |
IGC |
| AK |
Fox Chase |
Kidney renal clear cell carcinoma |
IGC |
| AL |
Fox Chase |
Kidney renal papillary cell carcinoma |
IGC |
| HH |
Fox Chase |
Stomach adenocarcinoma |
IGC |
| HI |
Fox Chase |
Prostate adenocarcinoma |
IGC |
| HJ |
Fox Chase |
Stomach adenocarcinoma |
IGC |
| HK |
Fox Chase |
Brain Lower Grade Glioma |
IGC |
| HL |
Fox Chase |
Head and Neck squamous cell carcinoma |
IGC |
| PC |
Fox Chase |
Sarcoma |
NCH |
| PD |
Fox Chase |
Liver hepatocellular carcinoma |
NCH |
| PE |
Fox Chase |
Breast invasive carcinoma |
NCH |
| 20 |
Fox Chase Cancer Center |
Ovarian serous cystadenocarcinoma |
IGC |
| 21 |
Fox Chase Cancer Center |
Lung squamous cell carcinoma |
IGC |
| P3 |
Fred Hutchinson |
Head and Neck squamous cell carcinoma |
NCH |
| GS |
Fundacio Clinic per a la Recerca Biomedica |
Lymphoid Neoplasm Diffuse Large B-cell Lymphoma |
IGC |
| US |
Garvan Institute of Medical Research |
Pancreatic adenocarcinoma |
NCH |
| W7 |
Garvan Institute of Medical Research |
Cholangiocarcinoma |
NCH |
| TE |
Global BioClinical - Georgia |
Skin Cutaneous Melanoma |
NCH |
| TG |
Global BioClinical - Georgia |
Head and Neck squamous cell carcinoma |
NCH |
| TK |
Global BioClinical - Georgia |
Prostate adenocarcinoma |
NCH |
| TL |
Global BioClinical - Georgia |
Stomach adenocarcinoma |
NCH |
| VB |
Global BioClinical - Georgia |
Lymphoid Neoplasm Diffuse Large B-cell Lymphoma |
NCH |
| ST |
Global Bioclinical-Moldova |
Head and Neck squamous cell carcinoma |
NCH |
| SU |
Global Bioclinical-Moldova |
Prostate adenocarcinoma |
NCH |
| SW |
Global Bioclinical-Moldova |
Stomach adenocarcinoma |
NCH |
| TR |
Global Bioclinical-Moldova |
Skin Cutaneous Melanoma |
NCH |
| D5 |
Greater Poland Cancer Center |
Colon adenocarcinoma |
IGC |
| D6 |
Greater Poland Cancer Center |
Head and Neck squamous cell carcinoma |
IGC |
| D7 |
Greater Poland Cancer Center |
Stomach adenocarcinoma |
IGC |
| D8 |
Greater Poland Cancer Center |
Breast invasive carcinoma |
NCH |
| D9 |
Greater Poland Cancer Center |
Skin Cutaneous Melanoma |
NCH |
| EI |
Greater Poland Cancer Center |
Rectum adenocarcinoma |
IGC |
| 2K |
Greenville Health System |
Kidney renal papillary cell carcinoma |
NCH |
| 3N |
Greenville Health System |
Skin Cutaneous Melanoma |
NCH |
| 3P |
Greenville Health System |
Ovarian serous cystadenocarcinoma |
NCH |
| W8 |
Greenville Health System |
Breast invasive carcinoma |
NCH |
| WF |
Greenville Health System |
Pancreatic adenocarcinoma |
NCH |
| WG |
Greenville Health System |
Lung squamous cell carcinoma |
NCH |
| WH |
Greenville Health System |
Brain Lower Grade Glioma |
NCH |
| WJ |
Greenville Health System |
Liver hepatocellular carcinoma |
NCH |
| 3Q |
Greenville Health Systems |
Thymoma |
NCH |
| PH |
Gundersen Lutheran |
Acute Myeloid Leukemia |
NCH |
| PJ |
Gundersen Lutheran |
Kidney renal papillary cell carcinoma |
NCH |
| L3 |
Gundersen Lutheran Health System |
Lung squamous cell carcinoma |
IGC |
| L4 |
Gundersen Lutheran Health System |
Lung adenocarcinoma |
IGC |
| LQ |
Gundersen Lutheran Health System |
Breast invasive carcinoma |
NCH |
| LS |
Gundersen Lutheran Health System |
Cervical squamous cell carcinoma and endocervical adenocarcinoma |
NCH |
| LT |
Gundersen Lutheran Health System |
Bladder Urothelial Carcinoma |
NCH |
| NS |
Gundersen Lutheran Health System |
Skin Cutaneous Melanoma |
NCH |
| R7 |
Gundersen Lutheran Health System |
Head and Neck squamous cell carcinoma |
NCH |
| S6 |
Gundersen Lutheran Health System |
Testicular Germ Cell Tumors |
NCH |
| 04 |
Gynecologic Oncology Group |
Ovarian serous cystadenocarcinoma |
IGC |
| AX |
Gynecologic Oncology Group |
Uterine Corpus Endometrial Carcinoma |
NCH |
| EK |
Gynecologic Oncology Group |
Cervical squamous cell carcinoma and endocervical adenocarcinoma |
NCH |
| KT |
Hartford |
Brain Lower Grade Glioma |
IGC |
| KU |
Hartford |
Head and Neck squamous cell carcinoma |
IGC |
| KV |
Hartford |
Kidney renal papillary cell carcinoma |
IGC |
| KZ |
Hartford |
Stomach adenocarcinoma |
IGC |
| L1 |
Hartford |
Pancreatic adenocarcinoma |
IGC |
| LC |
Hartford Hospital |
Bladder Urothelial Carcinoma |
NCH |
| LD |
Hartford Hospital |
Breast invasive carcinoma |
NCH |
| LG |
Hartford Hospital |
Liver hepatocellular carcinoma |
NCH |
| LH |
Hartford Hospital |
Skin Cutaneous Melanoma |
NCH |
| LI |
Hartford Hospital |
Sarcoma |
NCH |
| 30 |
Harvard |
Ovarian serous cystadenocarcinoma |
IGC |
| CK |
Harvard |
Colon adenocarcinoma |
IGC |
| CL |
Harvard |
Rectum adenocarcinoma |
IGC |
| CZ |
Harvard |
Kidney renal clear cell carcinoma |
IGC |
| KN |
Harvard |
Kidney Chromophobe |
IGC |
| QU |
Harvard Beth Israel |
Prostate adenocarcinoma |
NCH |
| 06 |
Henry Ford Hospital |
Glioblastoma multiforme |
IGC |
| DU |
Henry Ford Hospital |
Brain Lower Grade Glioma |
IGC |
| 5S |
Holy Cross |
Uterine Corpus Endometrial Carcinoma |
NCH |
| 5T |
Holy Cross |
Breast invasive carcinoma |
NCH |
| 4V |
Hospital Louis Pradel |
Thymoma |
NCH |
| VM |
Huntsman Cancer Institute |
Brain Lower Grade Glioma |
NCH |
| Z2 |
IDI-IRCCS |
Skin Cutaneous Melanoma |
NCH |
| 70 |
ILSBio |
Lung squamous cell carcinoma |
IGC |
| 71 |
ILSBio |
Lung adenocarcinoma |
IGC |
| C8 |
ILSBio |
Breast invasive carcinoma |
NCH |
| C9 |
ILSBio |
Head and Neck squamous cell carcinoma |
NCH |
| CA |
ILSBio |
Colon adenocarcinoma |
IGC |
| CB |
ILSBio |
Kidney renal clear cell carcinoma |
IGC |
| CC |
ILSBio |
Liver hepatocellular carcinoma |
NCH |
| CD |
ILSBio |
Stomach adenocarcinoma |
IGC |
| CE |
ILSBio |
Thyroid carcinoma |
IGC |
| CF |
ILSBio |
Bladder Urothelial Carcinoma |
NCH |
| DT |
ILSBio |
Rectum adenocarcinoma |
IGC |
| J7 |
ILSBio |
Kidney renal papillary cell carcinoma |
IGC |
| LN |
ILSBIO |
Esophageal carcinoma |
NCH |
| LP |
ILSBIO |
Cervical squamous cell carcinoma and endocervical adenocarcinoma |
NCH |
| MO |
ILSBio |
Sarcoma |
NCH |
| QN |
ILSBio |
Uterine Carcinosarcoma |
NCH |
| ZD |
ILSbio |
Cholangiocarcinoma |
NCH |
| 31 |
Imperial College |
Ovarian serous cystadenocarcinoma |
IGC |
| 05 |
Indivumed |
Lung adenocarcinoma |
IGC |
| 66 |
Indivumed |
Lung squamous cell carcinoma |
IGC |
| A8 |
Indivumed |
Breast invasive carcinoma |
NCH |
| AA |
Indivumed |
Colon adenocarcinoma |
IGC |
| AG |
Indivumed |
Rectum adenocarcinoma |
IGC |
| C4 |
Indivumed |
Bladder Urothelial Carcinoma |
NCH |
| CG |
Indivumed |
Stomach adenocarcinoma |
IGC |
| CH |
Indivumed |
Prostate adenocarcinoma |
IGC |
| V4 |
Institut Curie |
Uveal Melanoma |
NCH |
| X4 |
Institute for Medical Research |
Prostate adenocarcinoma |
NCH |
| PL |
Institute of Human Virology Nigeria |
Breast invasive carcinoma |
NCH |
| PN |
Institute of Human Virology Nigeria |
Cervical squamous cell carcinoma and endocervical adenocarcinoma |
NCH |
| VG |
Institute of Human Virology Nigeria |
Ovarian serous cystadenocarcinoma |
NCH |
| VK |
Institute of Human Virology Nigeria |
Colon adenocarcinoma |
NCH |
| VL |
Institute of Human Virology Nigeria |
Rectum adenocarcinoma |
NCH |
| X5 |
Institute of Human Virology Nigeria |
Bladder Urothelial Carcinoma |
NCH |
| QV |
Instituto Nacional de Cancerologia |
Cervical squamous cell carcinoma and endocervical adenocarcinoma |
NCH |
| QW |
Instituto Nacional de Cancerologia |
Stomach adenocarcinoma |
NCH |
| AJ |
International Genomics Conosrtium |
Uterine Corpus Endometrial Carcinoma |
NCH |
| 01 |
International Genomics Consortium |
Ovarian serous cystadenocarcinoma |
IGC |
| 55 |
International Genomics Consortium |
Lung adenocarcinoma |
IGC |
| 56 |
International Genomics Consortium |
Lung squamous cell carcinoma |
IGC |
| 57 |
International Genomics Consortium |
Ovarian serous cystadenocarcinoma |
IGC |
| 87 |
International Genomics Consortium |
Glioblastoma multiforme |
IGC |
| A3 |
International Genomics Consortium |
Kidney renal clear cell carcinoma |
IGC |
| A4 |
International Genomics Consortium |
Kidney renal papillary cell carcinoma |
IGC |
| AC |
International Genomics Consortium |
Breast invasive carcinoma |
NCH |
| AD |
International Genomics Consortium |
Colon adenocarcinoma |
IGC |
| AH |
International Genomics Consortium |
Rectum adenocarcinoma |
IGC |
| FM |
International Genomics Consortium |
Lymphoid Neoplasm Diffuse Large B-cell Lymphoma |
IGC |
| FN |
International Genomics Consortium |
Brain Lower Grade Glioma |
IGC |
| FP |
International Genomics Consortium |
Stomach adenocarcinoma |
IGC |
| FU |
International Genomics Consortium |
Cervical squamous cell carcinoma and endocervical adenocarcinoma |
NCH |
| FV |
International Genomics Consortium |
Liver hepatocellular carcinoma |
NCH |
| FW |
International Genomics Consortium |
Skin Cutaneous Melanoma |
NCH |
| FX |
International Genomics Consortium |
Sarcoma |
NCH |
| FY |
International Genomics Consortium |
Thyroid carcinoma |
NCH |
| GC |
International Genomics Consortium |
Bladder Urothelial Carcinoma |
NCH |
| HC |
International Genomics Consortium |
Prostate adenocarcinoma |
IGC |
| HD |
International Genomics Consortium |
Head and Neck squamous cell carcinoma |
IGC |
| HZ |
International Genomics Consortium |
Pancreatic adenocarcinoma |
IGC |
| NP |
International Genomics Consortium |
Kidney Chromophobe |
NCH |
| NQ |
International Genomics Consortium |
Mesothelioma |
NCH |
| OW |
International Genomics Consortium |
Miscellaneous |
NCH |
| SQ |
International Genomics Consortium |
Pheochromocytoma and Paraganglioma |
NCH |
| WZ |
International Genomics Consortium |
Testicular Germ Cell Tumors |
NCH |
| ZT |
International Genomics Consortium |
Thymoma |
NCH |
| VV |
John Wayne Cancer Center |
Brain Lower Grade Glioma |
NCH |
| W3 |
John Wayne Cancer Center |
Skin Cutaneous Melanoma |
NCH |
| Z7 |
John Wayne Cancer Center |
Breast invasive carcinoma |
NCH |
| Z8 |
John Wayne Cancer Center |
Pancreatic adenocarcinoma |
NCH |
| 1Z |
Johns Hopkins |
Thymoma |
NCH |
| 33 |
Johns Hopkins |
Lung squamous cell carcinoma |
IGC |
| 49 |
Johns Hopkins |
Lung adenocarcinoma |
IGC |
| BB |
Johns Hopkins |
Head and Neck squamous cell carcinoma |
IGC |
| ET |
Johns Hopkins |
Thyroid carcinoma |
NCH |
| FK |
Johns Hopkins |
Thyroid carcinoma |
NCH |
| FQ |
Johns Hopkins |
Pancreatic adenocarcinoma |
IGC |
| WY |
Johns Hopkins |
Brain Lower Grade Glioma |
NCH |
| XT |
Johns Hopkins |
Mesothelioma |
NCH |
| PT |
Maine Medical Center |
Sarcoma |
NCH |
| TP |
Maine Medical Center |
Prostate adenocarcinoma |
NCH |
| 3Z |
Mary Bird Perkins Cancer Center - Our Lady of the Lake |
Kidney renal clear cell carcinoma |
NCH |
| 4A |
Mary Bird Perkins Cancer Center - Our Lady of the Lake |
Kidney renal papillary cell carcinoma |
NCH |
| 4B |
Mary Bird Perkins Cancer Center - Our Lady of the Lake |
Lung adenocarcinoma |
NCH |
| 4C |
Mary Bird Perkins Cancer Center - Our Lady of the Lake |
Thyroid carcinoma |
NCH |
| 4N |
Mary Bird Perkins Cancer Center - Our Lady of the Lake |
Colon adenocarcinoma |
NCH |
| UU |
Mary Bird Perkins Cancer Center - Our Lady of the Lake |
Breast invasive carcinoma |
NCH |
| AR |
Mayo |
Breast invasive carcinoma |
NCH |
| 2J |
Mayo Clinic |
Pancreatic adenocarcinoma |
NCH |
| D1 |
Mayo Clinic |
Uterine Corpus Endometrial Carcinoma |
NCH |
| J8 |
Mayo Clinic |
Thyroid carcinoma |
NCH |
| 15 |
Mayo Clinic - Rochester |
Glioblastoma multiforme |
IGC |
| 22 |
Mayo Clinic - Rochester |
Lung squamous cell carcinoma |
IGC |
| 25 |
Mayo Clinic - Rochester |
Ovarian serous cystadenocarcinoma |
IGC |
| CW |
Mayo Clinic - Rochester |
Kidney renal clear cell carcinoma |
IGC |
| DB |
Mayo Clinic - Rochester |
Brain Lower Grade Glioma |
IGC |
| DD |
Mayo Clinic - Rochester |
Liver hepatocellular carcinoma |
NCH |
| DZ |
Mayo Clinic - Rochester |
Kidney renal papillary cell carcinoma |
IGC |
| NF |
Mayo Clinic - Rochester |
Uterine Carcinosarcoma |
NCH |
| SX |
Mayo Clinic Arizona |
Kidney renal papillary cell carcinoma |
NCH |
| SY |
Mayo Clinic Arizona |
Bladder Urothelial Carcinoma |
NCH |
| XK |
Mayo Clinic Arizona |
Prostate adenocarcinoma |
NCH |
| W5 |
Mayo Clinic Rochester |
Cholangiocarcinoma |
NCH |
| D3 |
MD Anderson |
Skin Cutaneous Melanoma |
NCH |
| DI |
MD Anderson |
Uterine Corpus Endometrial Carcinoma |
NCH |
| EL |
MD Anderson |
Thyroid carcinoma |
NCH |
| G2 |
MD Anderson |
Bladder Urothelial Carcinoma |
NCH |
| GM |
MD Anderson |
Breast invasive carcinoma |
NCH |
| GP |
MD Anderson |
Acute Myeloid Leukemia |
NCH |
| N9 |
MD Anderson |
Uterine Carcinosarcoma |
NCH |
| R8 |
MD Anderson |
Brain Lower Grade Glioma |
NCH |
| SD |
MD Anderson |
Pancreatic adenocarcinoma |
NCH |
| WC |
MD Anderson |
Uveal Melanoma |
NCH |
| 02 |
MD Anderson Cancer Center |
Glioblastoma multiforme |
IGC |
| 10 |
MD Anderson Cancer Center |
Ovarian serous cystadenocarcinoma |
IGC |
| 11 |
MD Anderson Cancer Center |
Lung squamous cell carcinoma |
IGC |
| 3G |
MD Anderson Cancer Center |
Thymoma |
NCH |
| 3H |
MD Anderson Cancer Center |
Mesothelioma |
NCH |
| CJ |
MD Anderson Cancer Center |
Kidney renal clear cell carcinoma |
IGC |
| CV |
MD Anderson Cancer Center |
Head and Neck squamous cell carcinoma |
IGC |
| KK |
MD Anderson Cancer Center |
Prostate adenocarcinoma |
IGC |
| KO |
MD Anderson Cancer Center |
Kidney Chromophobe |
IGC |
| MA |
MD Anderson Cancer Center |
Cervical squamous cell carcinoma and endocervical adenocarcinoma |
NCH |
| P4 |
MD Anderson Cancer Center |
Kidney renal papillary cell carcinoma |
NCH |
| R5 |
MD Anderson Cancer Center |
Stomach adenocarcinoma |
NCH |
| R6 |
MD Anderson Cancer Center |
Esophageal carcinoma |
NCH |
| CX |
Medical College of Georgia |
Head and Neck squamous cell carcinoma |
IGC |
| DO |
Medical College of Georgia |
Thyroid carcinoma |
NCH |
| H1 |
Medical College of Georgia |
Stomach adenocarcinoma |
IGC |
| H4 |
Medical College of Georgia |
Bladder Urothelial Carcinoma |
NCH |
| H5 |
Medical College of Georgia |
Uterine Corpus Endometrial Carcinoma |
NCH |
| SS |
Medical College of Georgia |
Colon adenocarcinoma |
NCH |
| V7 |
Medical College of Georgia |
Breast invasive carcinoma |
NCH |
| V8 |
Medical College of Georgia |
Kidney renal clear cell carcinoma |
NCH |
| V9 |
Medical College of Georgia |
Kidney renal papillary cell carcinoma |
NCH |
| 4Y |
Medical College of Wisconsin |
Sarcoma |
NCH |
| 5B |
Medical College of Wisconsin |
Uterine Corpus Endometrial Carcinoma |
NCH |
| C5 |
Medical College of Wisconsin |
Cervical squamous cell carcinoma and endocervical adenocarcinoma |
NCH |
| W2 |
Medical College of Wisconsin |
Pheochromocytoma and Paraganglioma |
NCH |
| ZP |
Medical College of Wisconsin |
Liver hepatocellular carcinoma |
NCH |
| J9 |
Melbourne Health |
Prostate adenocarcinoma |
IGC |
| 13 |
Memorial Sloan Kettering |
Ovarian serous cystadenocarcinoma |
IGC |
| DJ |
Memorial Sloan Kettering |
Thyroid carcinoma |
NCH |
| DK |
Memorial Sloan Kettering |
Bladder Urothelial Carcinoma |
NCH |
| DX |
Memorial Sloan Kettering |
Sarcoma |
NCH |
| IR |
Memorial Sloan Kettering |
Cervical squamous cell carcinoma and endocervical adenocarcinoma |
NCH |
| IS |
Memorial Sloan Kettering |
Sarcoma |
NCH |
| KH |
Memorial Sloan Kettering |
Esophageal carcinoma |
NCH |
| SC |
Memorial Sloan Kettering |
Mesothelioma |
NCH |
| 2A |
Memorial Sloan Kettering Cancer Center |
Prostate adenocarcinoma |
NCH |
| RS |
Memorial Sloan Kettering Cancer Center |
Head and Neck squamous cell carcinoma |
NCH |
| RW |
Michigan University |
Pheochromocytoma and Paraganglioma |
NCH |
| 27 |
Milan - Italy, Fondazione IRCCS Instituto Neuroligico C. Besta |
Glioblastoma multiforme |
IGC |
| 2Y |
Moffitt Cancer Center |
Liver hepatocellular carcinoma |
NCH |
| 2Z |
Moffitt Cancer Center |
Kidney renal papillary cell carcinoma |
NCH |
| 3A |
Moffitt Cancer Center |
Pancreatic adenocarcinoma |
NCH |
| 3B |
Moffitt Cancer Center |
Sarcoma |
NCH |
| 4D |
Molecular Response |
Ovarian serous cystadenocarcinoma |
NCH |
| 4E |
Molecular Response |
Uterine Corpus Endometrial Carcinoma |
NCH |
| T3 |
Molecular Response |
Head and Neck squamous cell carcinoma |
NCH |
| T6 |
Molecular Response |
Lung adenocarcinoma |
NCH |
| T7 |
Molecular Response |
Kidney renal clear cell carcinoma |
NCH |
| T9 |
Molecular Response |
Colon adenocarcinoma |
NCH |
| MY |
Montefiore Medical Center |
Cervical squamous cell carcinoma and endocervical adenocarcinoma |
NCH |
| MZ |
Montefiore Medical Center |
Head and Neck squamous cell carcinoma |
NCH |
| N1 |
Montefiore Medical Center |
Sarcoma |
NCH |
| PG |
Montefiore Medical Center |
Uterine Corpus Endometrial Carcinoma |
NCH |
| RG |
Montefiore Medical Center |
Liver hepatocellular carcinoma |
NCH |
| KD |
Mount Sinai School of Medicine |
Sarcoma |
NCH |
| KE |
Mount Sinai School of Medicine |
Uterine Corpus Endometrial Carcinoma |
NCH |
| OK |
Mount Sinai School of Medicine |
Breast invasive carcinoma |
NCH |
| QJ |
Mount Sinai School of Medicine |
Ovarian serous cystadenocarcinoma |
NCH |
| 39 |
MSKCC |
Lung squamous cell carcinoma |
IGC |
| AO |
MSKCC |
Breast invasive carcinoma |
NCH |
| AP |
MSKCC |
Uterine Corpus Endometrial Carcinoma |
NCH |
| BP |
MSKCC |
Kidney renal clear cell carcinoma |
IGC |
| BQ |
MSKCC |
Kidney renal papillary cell carcinoma |
IGC |
| CM |
MSKCC |
Colon adenocarcinoma |
IGC |
| DC |
MSKCC |
Rectum adenocarcinoma |
IGC |
| HW |
MSKCC |
Brain Lower Grade Glioma |
IGC |
| KL |
MSKCC |
Kidney Chromophobe |
IGC |
| MX |
MSKCC |
Stomach adenocarcinoma |
NCH |
| N5 |
MSKCC |
Uterine Carcinosarcoma |
NCH |
| XM |
MSKCC |
Thymoma |
NCH |
| YV |
MSKCC |
Uveal Melanoma |
NCH |
| HU |
National Cancer Center Korea |
Stomach adenocarcinoma |
IGC |
| HV |
National Cancer Center Korea |
Pancreatic adenocarcinoma |
IGC |
| L6 |
National Institutes of Health |
Thyroid carcinoma |
NCH |
| QR |
National Institutes of Health |
Pheochromocytoma and Paraganglioma |
NCH |
| 72 |
NCH |
Ovarian serous cystadenocarcinoma |
IGC |
| AV |
NCH |
Cell Line Control |
NCH |
| ZJ |
NCI HRE Branch |
Cervical squamous cell carcinoma and endocervical adenocarcinoma |
NCH |
| DV |
NCI Urologic Oncology Branch |
Kidney renal clear cell carcinoma |
IGC |
| DW |
NCI Urologic Oncology Branch |
Kidney renal papillary cell carcinoma |
IGC |
| KM |
NCI Urologic Oncology Branch |
Kidney Chromophobe |
IGC |
| VN |
NCI Urologic Oncology Branch |
Prostate adenocarcinoma |
NCH |
| WE |
Norfolk and Norwich Hospital |
Skin Cutaneous Melanoma |
NCH |
| RU |
Northwestern University |
Colon adenocarcinoma |
NCH |
| RV |
Northwestern University |
Pancreatic adenocarcinoma |
NCH |
| VW |
Northwestern University |
Brain Lower Grade Glioma |
NCH |
| VX |
Northwestern University |
Stomach adenocarcinoma |
NCH |
| FE |
Ohio State University |
Thyroid carcinoma |
NCH |
| TN |
Ohio State University |
Head and Neck squamous cell carcinoma |
NCH |
| 63 |
Ontario Institute for Cancer Research |
Lung squamous cell carcinoma |
IGC |
| DF |
Ontario Institute for Cancer Research |
Uterine Corpus Endometrial Carcinoma |
NCH |
| DG |
Ontario Institute for Cancer Research |
Cervical squamous cell carcinoma and endocervical adenocarcinoma |
NCH |
| 75 |
Ontario Institute for Cancer Research (OICR) |
Lung adenocarcinoma |
IGC |
| HE |
Ontario Institute for Cancer Research (OICR) |
Kidney renal papillary cell carcinoma |
IGC |
| HF |
Ontario Institute for Cancer Research (OICR) |
Stomach adenocarcinoma |
IGC |
| HN |
Ontario Institute for Cancer Research (OICR) |
Breast invasive carcinoma |
NCH |
| HP |
Ontario Institute for Cancer Research (OICR) |
Liver hepatocellular carcinoma |
NCH |
| HQ |
Ontario Institute for Cancer Research (OICR) |
Bladder Urothelial Carcinoma |
NCH |
| HR |
Ontario Institute for Cancer Research (OICR) |
Skin Cutaneous Melanoma |
NCH |
| HS |
Ontario Institute for Cancer Research (OICR) |
Sarcoma |
NCH |
| M8 |
Ontario Institute for Cancer Research (OICR) |
Pancreatic adenocarcinoma |
NCH |
| M9 |
Ontario Institute for Cancer Research (OICR) |
Esophageal carcinoma |
NCH |
| 79 |
Ontario Institute for Cancer Research (OICR)/Ottawa |
Lung squamous cell carcinoma |
IGC |
| 80 |
Ontario Institute for Cancer Research (OICR)/Ottawa |
Lung adenocarcinoma |
IGC |
| SH |
Papworth Hospital |
Mesothelioma |
NCH |
| RD |
Peter MacCallum Cancer Center |
Stomach adenocarcinoma |
NCH |
| RE |
Peter MacCallum Cancer Center |
Esophageal carcinoma |
NCH |
| 77 |
Prince Charles Hospital |
Lung squamous cell carcinoma |
IGC |
| 78 |
Prince Charles Hospital |
Lung adenocarcinoma |
IGC |
| 18 |
Princess Margaret Hospital (Canada) |
Lung squamous cell carcinoma |
IGC |
| YL |
PROCURE Biobank |
Prostate adenocarcinoma |
NCH |
| 5Q |
Proteogenex, Inc |
Pancreatic adenocarcinoma |
NCH |
| 5R |
Proteogenex, Inc |
Liver hepatocellular carcinoma |
NCH |
| 4H |
Proteogenex, Inc. |
Breast invasive carcinoma |
NCH |
| 4J |
Proteogenex, Inc. |
Cervical squamous cell carcinoma and endocervical adenocarcinoma |
NCH |
| 4K |
Proteogenex, Inc. |
Testicular Germ Cell Tumors |
NCH |
| 4L |
Proteogenex, Inc. |
Prostate adenocarcinoma |
NCH |
| XD |
Providence Portland Medical Center |
Pancreatic adenocarcinoma |
NCH |
| 5U |
Regina Elena National Cancer Institute |
Thymoma |
NCH |
| 5H |
Retina Consultants Houston |
Uveal Melanoma |
NCH |
| GN |
Roswell |
Skin Cutaneous Melanoma |
NCH |
| 59 |
Roswell Park |
Ovarian serous cystadenocarcinoma |
IGC |
| 5V |
Roswell Park |
Thymoma |
NCH |
| 60 |
Roswell Park |
Lung squamous cell carcinoma |
IGC |
| 65 |
Roswell Park |
Glioblastoma multiforme |
IGC |
| 73 |
Roswell Park |
Lung adenocarcinoma |
IGC |
| E2 |
Roswell Park |
Breast invasive carcinoma |
NCH |
| E3 |
Roswell Park |
Thyroid carcinoma |
NCH |
| E5 |
Roswell Park |
Bladder Urothelial Carcinoma |
NCH |
| E6 |
Roswell Park |
Uterine Corpus Endometrial Carcinoma |
NCH |
| G4 |
Roswell Park |
Colon adenocarcinoma |
IGC |
| G5 |
Roswell Park |
Rectum adenocarcinoma |
IGC |
| G6 |
Roswell Park |
Kidney renal clear cell carcinoma |
IGC |
| G7 |
Roswell Park |
Kidney renal papillary cell carcinoma |
IGC |
| G8 |
Roswell Park |
Lymphoid Neoplasm Diffuse Large B-cell Lymphoma |
IGC |
| G9 |
Roswell Park |
Prostate adenocarcinoma |
IGC |
| HG |
Roswell Park |
Cervical squamous cell carcinoma and endocervical adenocarcinoma |
NCH |
| NG |
Roswell Park |
Uterine Carcinosarcoma |
NCH |
| NI |
Roswell Park |
Liver hepatocellular carcinoma |
NCH |
| OU |
Roswell Park |
Adrenocortical carcinoma |
NCH |
| PR |
Roswell Park |
Pheochromocytoma and Paraganglioma |
NCH |
| QQ |
Roswell Park |
Sarcoma |
NCH |
| YY |
Roswell Park |
Pancreatic adenocarcinoma |
NCH |
| O8 |
Saint Mary's Health Care |
Liver hepatocellular carcinoma |
NCH |
| O9 |
Saint Mary's Health Care |
Kidney renal papillary cell carcinoma |
NCH |
| OC |
Saint Mary's Health Care |
Lung squamous cell carcinoma |
NCH |
| OD |
Saint Mary's Health Care |
Skin Cutaneous Melanoma |
NCH |
| OE |
Saint Mary's Health Care |
Pancreatic adenocarcinoma |
NCH |
| OJ |
Saint Mary's Health Care |
Thyroid carcinoma |
NCH |
| 4G |
Sapienza University of Rome |
Cholangiocarcinoma |
NCH |
| FF |
SingHealth |
Lymphoid Neoplasm Diffuse Large B-cell Lymphoma |
IGC |
| XX |
Spectrum Health |
Breast invasive carcinoma |
NCH |
| XY |
Spectrum Health |
Testicular Germ Cell Tumors |
NCH |
| Y8 |
Spectrum Health |
Kidney renal papillary cell carcinoma |
NCH |
| YA |
Spectrum Health |
Liver hepatocellular carcinoma |
NCH |
| YB |
Spectrum Health |
Pancreatic adenocarcinoma |
NCH |
| YC |
Spectrum Health |
Bladder Urothelial Carcinoma |
NCH |
| YD |
Spectrum Health |
Skin Cutaneous Melanoma |
NCH |
| ZE |
Spectrum Health |
Lung squamous cell carcinoma |
NCH |
| ZU |
Spectrum Health |
Cholangiocarcinoma |
NCH |
| 67 |
St Joseph's Medical Center (MD) |
Lung adenocarcinoma |
IGC |
| 32 |
St. Joseph's Hospital (AZ) |
Glioblastoma multiforme |
IGC |
| T1 |
St. Joseph's Hospital Arizona |
Liver hepatocellular carcinoma |
NCH |
| X8 |
St. Joseph's Hospital Arizona |
Esophageal carcinoma |
NCH |
| 5K |
St. Joseph's Hospital AZ |
Thymoma |
NCH |
| RL |
St. Joseph's Hospital AZ |
Pancreatic adenocarcinoma |
NCH |
| RM |
St. Joseph's Hospital AZ |
Pheochromocytoma and Paraganglioma |
NCH |
| RN |
St. Joseph's Hospital AZ |
Sarcoma |
NCH |
| RP |
St. Joseph's Hospital AZ |
Skin Cutaneous Melanoma |
NCH |
| RQ |
St. Joseph's Hospital AZ |
Lymphoid Neoplasm Diffuse Large B-cell Lymphoma |
NCH |
| RR |
St. Joseph's Hospital AZ |
Glioblastoma multiforme |
NCH |
| SK |
St. Joseph's Hospital AZ |
Colon adenocarcinoma |
NCH |
| SL |
St. Joseph's Hospital AZ |
Uterine Corpus Endometrial Carcinoma |
NCH |
| 46 |
St. Joseph's Medical Center (MD) |
Lung squamous cell carcinoma |
IGC |
| AS |
St. Joseph's Medical Center-(MD) |
Kidney renal clear cell carcinoma |
IGC |
| AT |
St. Joseph's Medical Center-(MD) |
Kidney renal papillary cell carcinoma |
IGC |
| AU |
St. Joseph's Medical Center-(MD) |
Colon adenocarcinoma |
IGC |
| BW |
St. Joseph's Medical Center-(MD) |
Liver hepatocellular carcinoma |
NCH |
| T2 |
St. University of Colorado Denver |
Head and Neck squamous cell carcinoma |
NCH |
| YH |
Stanford University |
Pancreatic adenocarcinoma |
NCH |
| YJ |
Stanford University |
Prostate adenocarcinoma |
NCH |
| 74 |
Swedish Neurosciences |
Glioblastoma multiforme |
IGC |
| ZQ |
Tayside Tissue Bank |
Stomach adenocarcinoma |
NCH |
| ZR |
Tayside Tissue Bank |
Esophageal carcinoma |
NCH |
| ZS |
Tayside Tissue Bank |
Liver hepatocellular carcinoma |
NCH |
| 2L |
Technical University of Munich |
Pancreatic adenocarcinoma |
NCH |
| 2M |
Technical University of Munich |
Esophageal carcinoma |
NCH |
| 2N |
Technical University of Munich |
Stomach adenocarcinoma |
NCH |
| 6H |
Test For lcml |
Chronic Myelogenous Leukemia |
NCH |
| 07 |
TGen |
Cell Line Control |
IGC |
| YZ |
The Ohio State University |
Uveal Melanoma |
NCH |
| TM |
The University of New South Wales |
Brain Lower Grade Glioma |
NCH |
| 76 |
Thomas Jefferson University |
Glioblastoma multiforme |
IGC |
| CS |
Thomas Jefferson University |
Brain Lower Grade Glioma |
IGC |
| ZB |
Thoraxklinik |
Thymoma |
NCH |
| 58 |
Thoraxklinik at University Hospital Heidelberg |
Lung squamous cell carcinoma |
IGC |
| 62 |
Thoraxklinik at University Hospital Heidelberg |
Lung adenocarcinoma |
IGC |
| 16 |
Toronto Western Hospital |
Glioblastoma multiforme |
IGC |
| P6 |
Translational Genomics Research Institute |
Adrenocortical carcinoma |
NCH |
| P7 |
Translational Genomics Research Institute |
Pheochromocytoma and Paraganglioma |
NCH |
| SR |
Tufts Medical Center |
Pheochromocytoma and Paraganglioma |
NCH |
| Z3 |
UCLA |
Sarcoma |
NCH |
| 08 |
UCSF |
Glioblastoma multiforme |
IGC |
| 09 |
UCSF |
Ovarian serous cystadenocarcinoma |
IGC |
| A1 |
UCSF |
Breast invasive carcinoma |
NCH |
| UB |
UCSF |
Liver hepatocellular carcinoma |
NCH |
| W6 |
UCSF |
Cholangiocarcinoma |
NCH |
| 38 |
UNC |
Lung adenocarcinoma |
IGC |
| 51 |
UNC |
Lung squamous cell carcinoma |
IGC |
| AQ |
UNC |
Breast invasive carcinoma |
NCH |
| AY |
UNC |
Colon adenocarcinoma |
IGC |
| B8 |
UNC |
Kidney renal clear cell carcinoma |
IGC |
| B9 |
UNC |
Kidney renal papillary cell carcinoma |
IGC |
| BA |
UNC |
Head and Neck squamous cell carcinoma |
IGC |
| BC |
UNC |
Liver hepatocellular carcinoma |
NCH |
| BM |
UNC |
Rectum adenocarcinoma |
IGC |
| CU |
UNC |
Bladder Urothelial Carcinoma |
NCH |
| EZ |
UNC |
Brain Lower Grade Glioma |
IGC |
| F1 |
UNC |
Stomach adenocarcinoma |
IGC |
| F2 |
UNC |
Pancreatic adenocarcinoma |
IGC |
| EM |
University Health Network |
Thyroid carcinoma |
NCH |
| EO |
University Health Network |
Uterine Corpus Endometrial Carcinoma |
NCH |
| JY |
University Health Network |
Esophageal carcinoma |
NCH |
| PK |
University Health Network |
Adrenocortical carcinoma |
NCH |
| SP |
University Health Network |
Pheochromocytoma and Paraganglioma |
NCH |
| XU |
University Health Network |
Thymoma |
NCH |
| CQ |
University Health Network, Toronto |
Head and Neck squamous cell carcinoma |
IGC |
| KB |
University Health Network, Toronto |
Stomach adenocarcinoma |
IGC |
| 5N |
University Hospital Erlangen |
Bladder Urothelial Carcinoma |
NCH |
| 5P |
University Hospital Erlangen |
Kidney renal papillary cell carcinoma |
NCH |
| S7 |
University Hospital Motol |
Pheochromocytoma and Paraganglioma |
NCH |
| ZG |
University Medical Center Hamburg-Eppendorf |
Prostate adenocarcinoma |
NCH |
| 5W |
University of Alabama |
Uterine Corpus Endometrial Carcinoma |
NCH |
| 5X |
University of Alabama |
Ovarian serous cystadenocarcinoma |
NCH |
| ZW |
University of Alabama |
Pancreatic adenocarcinoma |
NCH |
| ZX |
University of Alabama |
Cervical squamous cell carcinoma and endocervical adenocarcinoma |
NCH |
| Y5 |
University of Arizona |
Sarcoma |
NCH |
| Y6 |
University of Arizona |
Prostate adenocarcinoma |
NCH |
| YN |
University of Arizona |
Skin Cutaneous Melanoma |
NCH |
| 2P |
University of California San Diego |
Pancreatic adenocarcinoma |
NCH |
| 2V |
University of California San Diego |
Liver hepatocellular carcinoma |
NCH |
| 3W |
University of California San Diego |
Sarcoma |
NCH |
| RY |
University of California San Francisco |
Brain Lower Grade Glioma |
NCH |
| UY |
University of California San Francisco |
Bladder Urothelial Carcinoma |
NCH |
| UZ |
University of California San Francisco |
Kidney renal papillary cell carcinoma |
NCH |
| V1 |
University of California San Francisco |
Prostate adenocarcinoma |
NCH |
| X9 |
University of California, Davis |
Sarcoma |
NCH |
| 3U |
University of Chicago |
Mesothelioma |
NCH |
| OL |
University of Chicago |
Breast invasive carcinoma |
NCH |
| QL |
University of Chicago |
Colon adenocarcinoma |
NCH |
| S4 |
University of Chicago |
Pancreatic adenocarcinoma |
NCH |
| PQ |
University of Colorado Denver |
Bladder Urothelial Carcinoma |
NCH |
| 26 |
University of Florida |
Glioblastoma multiforme |
IGC |
| DH |
University of Florida |
Brain Lower Grade Glioma |
IGC |
| ES |
University of Florida |
Liver hepatocellular carcinoma |
NCH |
| BS |
University of Hawaii |
Uterine Corpus Endometrial Carcinoma |
NCH |
| DR |
University of Hawaii |
Cervical squamous cell carcinoma and endocervical adenocarcinoma |
NCH |
| FL |
University of Hawaii - Normal Study |
Uterine Corpus Endometrial Carcinoma |
NCH |
| X6 |
University of Iowa |
Sarcoma |
NCH |
| 6A |
University of Kansas |
Lung squamous cell carcinoma |
NCH |
| W9 |
University of Kansas |
Brain Lower Grade Glioma |
NCH |
| WL |
University of Kansas |
Cervical squamous cell carcinoma and endocervical adenocarcinoma |
NCH |
| WM |
University of Kansas |
Kidney renal clear cell carcinoma |
NCH |
| WN |
University of Kansas |
Kidney renal papillary cell carcinoma |
NCH |
| WP |
University of Kansas |
Sarcoma |
NCH |
| WQ |
University of Kansas |
Liver hepatocellular carcinoma |
NCH |
| WR |
University of Kansas |
Ovarian serous cystadenocarcinoma |
NCH |
| WS |
University of Kansas |
Colon adenocarcinoma |
NCH |
| WT |
University of Kansas |
Breast invasive carcinoma |
NCH |
| XJ |
University of Kansas |
Prostate adenocarcinoma |
NCH |
| 2E |
University of Kansas Medical Center |
Uterine Corpus Endometrial Carcinoma |
NCH |
| 3M |
University of Kansas Medical Center |
Stomach adenocarcinoma |
NCH |
| VD |
University of Liverpool |
Uveal Melanoma |
NCH |
| ZC |
University of Mannheim |
Thymoma |
NCH |
| 4W |
University of Miami |
Glioblastoma multiforme |
NCH |
| 52 |
University of Miami |
Lung squamous cell carcinoma |
IGC |
| 53 |
University of Miami |
Lung adenocarcinoma |
IGC |
| 5D |
University of Miami |
Sarcoma |
NCH |
| EW |
University of Miami |
Breast invasive carcinoma |
NCH |
| IH |
University of Miami |
Skin Cutaneous Melanoma |
NCH |
| IM |
University of Miami |
Thyroid carcinoma |
NCH |
| IQ |
University of Miami |
Head and Neck squamous cell carcinoma |
IGC |
| KJ |
University of Miami |
Uterine Corpus Endometrial Carcinoma |
NCH |
| L8 |
University of Miami |
Kidney renal papillary cell carcinoma |
NCH |
| MW |
University of Miami |
Kidney renal clear cell carcinoma |
NCH |
| DM |
University Of Michigan |
Colon adenocarcinoma |
NCH |
| DQ |
University Of Michigan |
Head and Neck squamous cell carcinoma |
IGC |
| DY |
University Of Michigan |
Rectum adenocarcinoma |
NCH |
| KR |
University Of Michigan |
Liver hepatocellular carcinoma |
NCH |
| KS |
University Of Michigan |
Thyroid carcinoma |
NCH |
| L5 |
University of Michigan |
Esophageal carcinoma |
NCH |
| OR |
University of Michigan |
Adrenocortical carcinoma |
NCH |
| MB |
University of Minnesota |
Sarcoma |
NCH |
| ME |
University of Minnesota |
Lung adenocarcinoma |
NCH |
| MF |
University of Minnesota |
Lung squamous cell carcinoma |
NCH |
| MR |
University of Minnesota |
Liver hepatocellular carcinoma |
NCH |
| MS |
University of Minnesota |
Breast invasive carcinoma |
NCH |
| MT |
University of Minnesota |
Head and Neck squamous cell carcinoma |
NCH |
| MU |
University of Minnesota |
Cervical squamous cell carcinoma and endocervical adenocarcinoma |
NCH |
| MV |
University of Minnesota |
Bladder Urothelial Carcinoma |
NCH |
| P9 |
University of Minnesota |
Pancreatic adenocarcinoma |
NCH |
| PA |
University of Minnesota |
Adrenocortical carcinoma |
NCH |
| PB |
University of Minnesota |
Lymphoid Neoplasm Diffuse Large B-cell Lymphoma |
NCH |
| RX |
University of Minnesota |
Pheochromocytoma and Paraganglioma |
NCH |
| SO |
University of Minnesota |
Testicular Germ Cell Tumors |
NCH |
| XA |
University of Minnesota |
Prostate adenocarcinoma |
NCH |
| GR |
University of Nebraska Medical Center (UNMC) |
Lymphoid Neoplasm Diffuse Large B-cell Lymphoma |
IGC |
| 2W |
University of New Mexico |
Cervical squamous cell carcinoma and endocervical adenocarcinoma |
NCH |
| 3R |
University of New Mexico |
Sarcoma |
NCH |
| 3S |
University of New Mexico |
Thymoma |
NCH |
| Y3 |
University of New Mexico |
Acute Myeloid Leukemia |
NCH |
| ZK |
University of New Mexico |
Cholangiocarcinoma |
NCH |
| DE |
University of North Carolina |
Thyroid carcinoma |
NCH |
| EX |
University of North Carolina |
Cervical squamous cell carcinoma and endocervical adenocarcinoma |
NCH |
| EY |
University of North Carolina |
Uterine Corpus Endometrial Carcinoma |
NCH |
| FR |
University of North Carolina |
Skin Cutaneous Melanoma |
NCH |
| HB |
University of North Carolina |
Sarcoma |
NCH |
| M7 |
University of North Carolina |
Prostate adenocarcinoma |
NCH |
| N8 |
University of North Carolina |
Uterine Carcinosarcoma |
NCH |
| OX |
University of North Carolina |
Glioblastoma multiforme |
NCH |
| OY |
University of North Carolina |
Ovarian serous cystadenocarcinoma |
NCH |
| QT |
University of North Carolina |
Pheochromocytoma and Paraganglioma |
NCH |
| UW |
University of North Carolina |
Kidney Chromophobe |
NCH |
| W4 |
University of North Carolina |
Testicular Germ Cell Tumors |
NCH |
| ZH |
University of North Carolina |
Cholangiocarcinoma |
NCH |
| 6D |
University of Oklahoma HSC |
Kidney renal clear cell carcinoma |
NCH |
| Q1 |
University of Oklahoma HSC |
Cervical squamous cell carcinoma and endocervical adenocarcinoma |
NCH |
| Q2 |
University of Oklahoma HSC |
Kidney renal papillary cell carcinoma |
NCH |
| Q3 |
University of Oklahoma HSC |
Pancreatic adenocarcinoma |
NCH |
| QM |
University of Oklahoma HSC |
Uterine Carcinosarcoma |
NCH |
| S5 |
University of Oklahoma HSC |
Bladder Urothelial Carcinoma |
NCH |
| TS |
University of Pennsylvania |
Mesothelioma |
NCH |
| TT |
University of Pennsylvania |
Pheochromocytoma and Paraganglioma |
NCH |
| VF |
University of Pennsylvania |
Testicular Germ Cell Tumors |
NCH |
| 34 |
University of Pittsburgh |
Lung squamous cell carcinoma |
IGC |
| 50 |
University of Pittsburgh |
Lung adenocarcinoma |
IGC |
| 61 |
University of Pittsburgh |
Ovarian serous cystadenocarcinoma |
IGC |
| AZ |
University of Pittsburgh |
Colon adenocarcinoma |
IGC |
| B0 |
University of Pittsburgh |
Kidney renal clear cell carcinoma |
IGC |
| B1 |
University of Pittsburgh |
Kidney renal papillary cell carcinoma |
IGC |
| BD |
University of Pittsburgh |
Liver hepatocellular carcinoma |
NCH |
| BG |
University of Pittsburgh |
Uterine Corpus Endometrial Carcinoma |
NCH |
| BH |
University of Pittsburgh |
Breast invasive carcinoma |
NCH |
| BI |
University of Pittsburgh |
Cervical squamous cell carcinoma and endocervical adenocarcinoma |
NCH |
| BJ |
University of Pittsburgh |
Thyroid carcinoma |
IGC |
| BT |
University of Pittsburgh |
Bladder Urothelial Carcinoma |
NCH |
| CI |
University of Pittsburgh |
Rectum adenocarcinoma |
IGC |
| CN |
University of Pittsburgh |
Head and Neck squamous cell carcinoma |
IGC |
| EJ |
University of Pittsburgh |
Prostate adenocarcinoma |
IGC |
| ER |
University of Pittsburgh |
Skin Cutaneous Melanoma |
NCH |
| FZ |
University of Pittsburgh |
Pancreatic adenocarcinoma |
IGC |
| IC |
University of Pittsburgh |
Esophageal carcinoma |
NCH |
| IN |
University of Pittsburgh |
Stomach adenocarcinoma |
IGC |
| K1 |
University of Pittsburgh |
Sarcoma |
NCH |
| LK |
University of Pittsburgh |
Mesothelioma |
NCH |
| N6 |
University of Pittsburgh |
Uterine Carcinosarcoma |
NCH |
| P8 |
University of Pittsburgh |
Pheochromocytoma and Paraganglioma |
NCH |
| YF |
University of Puerto Rico |
Bladder Urothelial Carcinoma |
NCH |
| YG |
University of Puerto Rico |
Skin Cutaneous Melanoma |
NCH |
| JZ |
University of Rochester |
Esophageal carcinoma |
NCH |
| 5L |
University of Sao Paulo |
Breast invasive carcinoma |
NCH |
| 5M |
University of Sao Paulo |
Colon adenocarcinoma |
NCH |
| 6G |
University of Sao Paulo |
Rectum adenocarcinoma |
NCH |
| TQ |
University of Sao Paulo |
Brain Lower Grade Glioma |
NCH |
| XN |
University of Sao Paulo |
Pancreatic adenocarcinoma |
NCH |
| XP |
University of Sao Paulo |
Esophageal carcinoma |
NCH |
| XQ |
University of Sao Paulo |
Prostate adenocarcinoma |
NCH |
| XR |
University of Sao Paulo |
Liver hepatocellular carcinoma |
NCH |
| XS |
University of Sao Paulo |
Cervical squamous cell carcinoma and endocervical adenocarcinoma |
NCH |
| WA |
University of Schleswig-Holstein |
Head and Neck squamous cell carcinoma |
NCH |
| ZF |
University of Sheffield |
Bladder Urothelial Carcinoma |
NCH |
| XE |
University of Southern California |
Testicular Germ Cell Tumors |
NCH |
| XF |
University of Southern California |
Bladder Urothelial Carcinoma |
NCH |
| EE |
University of Sydney |
Skin Cutaneous Melanoma |
NCH |
| IF |
University of Texas MD Anderson Cancer Center |
Sarcoma |
NCH |
| ZM |
University of Ulm |
Testicular Germ Cell Tumors |
NCH |
| RC |
University of Utah |
Liver hepatocellular carcinoma |
NCH |
| UC |
University of Washington |
Cervical squamous cell carcinoma and endocervical adenocarcinoma |
NCH |
| X2 |
University of Washington |
Sarcoma |
NCH |
| UD |
University of Western Australia |
Mesothelioma |
NCH |
| ZL |
Valley Hospital |
Thymoma |
NCH |
| VT |
Vanderbilt |
Sarcoma |
NCH |
| CR |
Vanderbilt University |
Head and Neck squamous cell carcinoma |
IGC |
| 5A |
Wake Forest University |
Cholangiocarcinoma |
NCH |
| TV |
Wake Forest University |
Breast invasive carcinoma |
NCH |
| WU |
Wake Forest University |
Colon adenocarcinoma |
NCH |
| WW |
Wake Forest University |
Prostate adenocarcinoma |
NCH |
| A2 |
Walter Reed |
Breast invasive carcinoma |
NCH |
| 17 |
Washington University |
Lung adenocarcinoma |
IGC |
| 24 |
Washington University |
Ovarian serous cystadenocarcinoma |
IGC |
| AB |
Washington University |
Acute Myeloid Leukemia |
NCH |
| FI |
Washington University |
Uterine Corpus Endometrial Carcinoma |
NCH |
| JX |
Washington University |
Cervical squamous cell carcinoma and endocervical adenocarcinoma |
NCH |
| N7 |
Washington University |
Uterine Carcinosarcoma |
NCH |
| VP |
Washington University |
Prostate adenocarcinoma |
NCH |
| 98 |
Washington University - Alabama |
Lung squamous cell carcinoma |
IGC |
| 99 |
Washington University - Alabama |
Lung adenocarcinoma |
IGC |
| O1 |
Washington University - CALGB |
Lung adenocarcinoma |
NCH |
| O2 |
Washington University - CALGB |
Lung squamous cell carcinoma |
NCH |
| NB |
Washington University - CHUV |
Lung adenocarcinoma |
NCH |
| NC |
Washington University - CHUV |
Lung squamous cell carcinoma |
NCH |
| 68 |
Washington University - Cleveland Clinic |
Lung squamous cell carcinoma |
IGC |
| 69 |
Washington University - Cleveland Clinic |
Lung adenocarcinoma |
IGC |
| 94 |
Washington University - Emory |
Lung squamous cell carcinoma |
IGC |
| 95 |
Washington University - Emory |
Lung adenocarcinoma |
IGC |
| MP |
Washington University - Mayo Clinic |
Lung adenocarcinoma |
NCH |
| 96 |
Washington University - NYU |
Lung squamous cell carcinoma |
IGC |
| 97 |
Washington University - NYU |
Lung adenocarcinoma |
IGC |
| MQ |
Washington University - NYU |
Mesothelioma |
NCH |
| NJ |
Washington University - Rush University |
Lung adenocarcinoma |
NCH |
| NK |
Washington University - Rush University |
Lung squamous cell carcinoma |
NCH |
| 92 |
Washington University - St. Louis |
Lung squamous cell carcinoma |
IGC |
| 93 |
Washington University - St. Louis |
Lung adenocarcinoma |
IGC |
| SI |
Washington University St. Louis |
Sarcoma |
NCH |
| RZ |
Wills Eye Institute |
Uveal Melanoma |
NCH |
| DA |
Yale |
Skin Cutaneous Melanoma |
NCH |
| 4X |
Yale University |
Thymoma |
NCH |
| WX |
Yale University |
Liver hepatocellular carcinoma |
NCH |